Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
COVID-19
|
208,077
|
6,935
|
C
|
Top
|
2
|
COVID-19 pandemic
|
188,338
|
6,277
|
GA
|
Top
|
3
|
Mpox
|
151,010
|
5,033
|
C
|
High
|
4
|
Norovirus
|
132,256
|
4,408
|
B
|
Top
|
5
|
COVID-19 vaccine
|
115,338
|
3,844
|
C
|
Top
|
6
|
Respiratory syncytial virus
|
114,543
|
3,818
|
B
|
High
|
7
|
Epstein–Barr virus
|
101,476
|
3,382
|
B
|
Top
|
8
|
Rabies
|
99,432
|
3,314
|
B
|
Top
|
9
|
Smallpox
|
96,109
|
3,203
|
GA
|
Top
|
10
|
Shingles
|
94,445
|
3,148
|
GA
|
Top
|
11
|
List of epidemics and pandemics
|
93,721
|
3,124
|
List
|
High
|
12
|
HIV/AIDS
|
93,012
|
3,100
|
GA
|
Top
|
13
|
Rhinovirus
|
85,243
|
2,841
|
C
|
High
|
14
|
Dengue fever
|
82,863
|
2,762
|
FA
|
Top
|
15
|
Polio
|
81,279
|
2,709
|
B
|
Top
|
16
|
Prion
|
81,064
|
2,702
|
GA
|
Top
|
17
|
Spanish flu
|
78,867
|
2,628
|
GA
|
Top
|
18
|
Human papillomavirus infection
|
78,194
|
2,606
|
B
|
Top
|
19
|
Creutzfeldt–Jakob disease
|
71,926
|
2,397
|
B
|
Top
|
20
|
Virus
|
67,072
|
2,235
|
FA
|
Top
|
21
|
Eastern equine encephalitis
|
64,873
|
2,162
|
C
|
Mid
|
22
|
HIV
|
63,459
|
2,115
|
GA
|
Top
|
23
|
West Nile virus
|
62,724
|
2,090
|
B
|
High
|
24
|
Hand, foot, and mouth disease
|
62,499
|
2,083
|
B
|
High
|
25
|
Chickenpox
|
60,896
|
2,029
|
B
|
Top
|
26
|
Infectious mononucleosis
|
59,186
|
1,972
|
B
|
Top
|
27
|
Canine parvovirus
|
57,107
|
1,903
|
B
|
Top
|
28
|
Molluscum contagiosum
|
57,089
|
1,902
|
B
|
High
|
29
|
Herpes simplex virus
|
57,035
|
1,901
|
B
|
Top
|
30
|
Hodgkin lymphoma
|
55,740
|
1,858
|
B
|
Top
|
31
|
Gastroenteritis
|
51,134
|
1,704
|
GA
|
Top
|
32
|
Respiratory syncytial virus vaccine
|
49,539
|
1,651
|
B
|
Mid
|
33
|
Bell's palsy
|
47,841
|
1,594
|
B
|
Top
|
34
|
Measles
|
46,337
|
1,544
|
B
|
Top
|
35
|
Rotavirus
|
45,539
|
1,517
|
FA
|
Top
|
36
|
Herpes
|
43,252
|
1,441
|
GA
|
Top
|
37
|
COVID-19 pandemic in the United States
|
42,057
|
1,401
|
B
|
Low
|
38
|
HPV vaccine
|
41,956
|
1,398
|
B
|
High
|
39
|
Nipah virus
|
39,245
|
1,308
|
Start
|
Mid
|
40
|
Rosalind Franklin
|
38,952
|
1,298
|
B
|
High
|
41
|
Canine distemper
|
38,558
|
1,285
|
B
|
Top
|
42
|
Cytomegalovirus
|
38,226
|
1,274
|
B
|
Top
|
43
|
SARS-CoV-2
|
36,583
|
1,219
|
B
|
Top
|
44
|
Influenza
|
35,366
|
1,178
|
FA
|
High
|
45
|
Influenza A virus
|
34,885
|
1,162
|
B
|
Top
|
46
|
Hepatitis B
|
34,647
|
1,154
|
GA
|
Top
|
47
|
Hepatitis C
|
33,957
|
1,131
|
GA
|
Top
|
48
|
Chronic wasting disease
|
32,448
|
1,081
|
C
|
Top
|
49
|
Common cold
|
32,096
|
1,069
|
GA
|
Top
|
50
|
Chikungunya
|
31,961
|
1,065
|
B
|
High
|
51
|
Variant Creutzfeldt–Jakob disease
|
31,174
|
1,039
|
B
|
High
|
52
|
COVID-19 lockdown in India
|
31,077
|
1,035
|
B
|
Mid
|
53
|
Yellow fever
|
30,711
|
1,023
|
B
|
Top
|
54
|
2023–2024 mpox epidemic
|
30,481
|
1,016
|
C
|
Mid
|
55
|
Croup
|
30,432
|
1,014
|
GA
|
Top
|
56
|
Mumps
|
29,198
|
973
|
B
|
Top
|
57
|
Coronavirus
|
28,981
|
966
|
C
|
High
|
58
|
Marburg virus
|
28,592
|
953
|
C
|
High
|
59
|
Timeline of the COVID-19 pandemic
|
28,121
|
937
|
List
|
Top
|
60
|
Vaccine
|
27,832
|
927
|
B
|
Top
|
61
|
Bacteriophage
|
27,346
|
911
|
B
|
Top
|
62
|
Ebola
|
27,269
|
908
|
B
|
Top
|
63
|
Monkeypox virus
|
27,133
|
904
|
C
|
Mid
|
64
|
Rubella
|
24,769
|
825
|
B
|
Top
|
65
|
Oropouche fever
|
24,732
|
824
|
C
|
Low
|
66
|
Varicella zoster virus
|
23,856
|
795
|
C
|
High
|
67
|
History of HIV/AIDS
|
23,389
|
779
|
B
|
Top
|
68
|
Genital wart
|
23,308
|
776
|
B
|
Top
|
69
|
Genital herpes
|
23,064
|
768
|
C
|
High
|
70
|
Cold sore
|
22,748
|
758
|
C
|
Top
|
71
|
Foot-and-mouth disease
|
22,331
|
744
|
B
|
High
|
72
|
Kaposi's sarcoma
|
21,891
|
729
|
C
|
Mid
|
73
|
Smallpox vaccine
|
21,696
|
723
|
B
|
Mid
|
74
|
HeLa
|
21,484
|
716
|
C
|
Mid
|
75
|
Pandemic
|
20,475
|
682
|
B
|
High
|
76
|
Hepatitis A
|
20,289
|
676
|
B
|
Top
|
77
|
Feline leukemia virus
|
19,754
|
658
|
C
|
High
|
78
|
COVID-19 lockdowns
|
19,646
|
654
|
B
|
Low
|
79
|
Edward Jenner
|
19,427
|
647
|
B
|
High
|
80
|
Adenoviridae
|
19,179
|
639
|
B
|
High
|
81
|
COVID-19 pandemic by country and territory
|
19,097
|
636
|
List
|
Top
|
82
|
Cervical cancer
|
18,646
|
621
|
B
|
High
|
83
|
Enterovirus
|
18,555
|
618
|
C
|
High
|
84
|
Feline infectious peritonitis
|
18,552
|
618
|
C
|
High
|
85
|
1978 smallpox outbreak in the United Kingdom
|
17,885
|
596
|
B
|
Low
|
86
|
COVID-19 pandemic in India
|
17,335
|
577
|
B
|
High
|
87
|
COVID-19 lab leak theory
|
17,263
|
575
|
B
|
Low
|
88
|
Messenger RNA
|
16,935
|
564
|
C
|
High
|
89
|
SARS
|
16,350
|
545
|
C
|
Top
|
90
|
Remdesivir
|
15,996
|
533
|
C
|
High
|
91
|
Amantadine
|
15,857
|
528
|
C
|
High
|
92
|
Epidemiology of HIV/AIDS
|
15,434
|
514
|
C
|
High
|
93
|
Influenza vaccine
|
15,322
|
510
|
B
|
Top
|
94
|
Human metapneumovirus
|
15,063
|
502
|
C
|
High
|
95
|
Parvovirus B19
|
15,027
|
500
|
C
|
Mid
|
96
|
2009 swine flu pandemic
|
14,885
|
496
|
GA
|
High
|
97
|
List of COVID-19 vaccine authorizations
|
14,651
|
488
|
List
|
Mid
|
98
|
Influenza A virus subtype H1N1
|
14,492
|
483
|
C
|
Top
|
99
|
Influenza B virus
|
14,475
|
482
|
C
|
High
|
100
|
Zika virus
|
14,378
|
479
|
B
|
Top
|
101
|
2022–2023 mpox outbreak
|
14,350
|
478
|
B
|
Mid
|
102
|
Orthohantavirus
|
13,988
|
466
|
B
|
Top
|
103
|
Bluetongue disease
|
13,955
|
465
|
B
|
High
|
104
|
West Nile fever
|
13,935
|
464
|
C
|
High
|
105
|
List of deaths due to COVID-19
|
13,661
|
455
|
List
|
High
|
106
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
13,592
|
453
|
C
|
Low
|
107
|
Rabies virus
|
13,591
|
453
|
C
|
Top
|
108
|
Operation Warp Speed
|
13,475
|
449
|
C
|
High
|
109
|
COVID-19 pandemic deaths
|
13,141
|
438
|
C
|
Low
|
110
|
Varicella vaccine
|
13,098
|
436
|
B
|
Top
|
111
|
Roseola
|
13,066
|
435
|
C
|
High
|
112
|
COVID-19 misinformation
|
13,012
|
433
|
C
|
Low
|
113
|
Antiviral drug
|
12,980
|
432
|
C
|
Top
|
114
|
Retrovirus
|
12,298
|
409
|
C
|
Top
|
115
|
Coxsackievirus
|
12,214
|
407
|
C
|
High
|
116
|
Rinderpest
|
12,155
|
405
|
B
|
High
|
117
|
SARS-CoV-2 Omicron variant
|
11,991
|
399
|
C
|
High
|
118
|
Origin of SARS-CoV-2
|
11,870
|
395
|
C
|
Mid
|
119
|
Variants of SARS-CoV-2
|
11,527
|
384
|
C
|
Mid
|
120
|
Feline immunodeficiency virus
|
11,418
|
380
|
C
|
High
|
121
|
Interferon
|
11,399
|
379
|
B
|
Top
|
122
|
Index case
|
11,174
|
372
|
Start
|
Low
|
123
|
HIV/AIDS in the United States
|
11,122
|
370
|
C
|
Low
|
124
|
2002–2004 SARS outbreak
|
11,037
|
367
|
B
|
Mid
|
125
|
Sapovirus
|
10,988
|
366
|
C
|
High
|
126
|
Smallpox virus retention debate
|
10,972
|
365
|
Start
|
Low
|
127
|
Myxomatosis
|
10,747
|
358
|
GA
|
High
|
128
|
Moderna
|
10,489
|
349
|
C
|
Low
|
129
|
Herpesviridae
|
10,458
|
348
|
C
|
Top
|
130
|
Avian influenza
|
10,452
|
348
|
B
|
High
|
131
|
Poliovirus
|
10,349
|
344
|
GA
|
High
|
132
|
Tobacco mosaic virus
|
10,039
|
334
|
C
|
High
|
133
|
Human parainfluenza viruses
|
10,039
|
334
|
C
|
Mid
|
134
|
Zidovudine
|
9,968
|
332
|
B
|
High
|
135
|
Merkel-cell carcinoma
|
9,968
|
332
|
C
|
Mid
|
136
|
Vaccination
|
9,871
|
329
|
B
|
Top
|
137
|
Japanese encephalitis
|
9,411
|
313
|
B
|
High
|
138
|
SARS-CoV-1
|
9,308
|
310
|
C
|
High
|
139
|
Alphapithovirus
|
9,134
|
304
|
C
|
High
|
140
|
Gardasil
|
9,111
|
303
|
B
|
High
|
141
|
Dengue virus
|
8,793
|
293
|
B
|
Top
|
142
|
Dengue vaccine
|
8,783
|
292
|
C
|
Low
|
143
|
Symptoms of COVID-19
|
8,730
|
291
|
C
|
Low
|
144
|
Viral hepatitis
|
8,684
|
289
|
C
|
High
|
145
|
Nipah virus infection
|
8,641
|
288
|
C
|
High
|
146
|
COVID-19 pandemic in the Philippines
|
8,633
|
287
|
B
|
Low
|
147
|
Viral pneumonia
|
8,384
|
279
|
Start
|
High
|
148
|
Compartmental models in epidemiology
|
8,356
|
278
|
C
|
Mid
|
149
|
Western African Ebola epidemic
|
8,096
|
269
|
GA
|
Mid
|
150
|
Virus classification
|
8,019
|
267
|
C
|
Top
|
151
|
Viral disease
|
7,957
|
265
|
List
|
Top
|
152
|
Timeline of HIV/AIDS
|
7,916
|
263
|
List
|
Mid
|
153
|
Disease X
|
7,907
|
263
|
GA
|
Low
|
154
|
COVID-19 pandemic in the United Kingdom
|
7,801
|
260
|
C
|
Low
|
155
|
Diagnosis of HIV/AIDS
|
7,793
|
259
|
B
|
High
|
156
|
Zaire ebolavirus
|
7,610
|
253
|
C
|
Top
|
157
|
Human herpesvirus 6
|
7,596
|
253
|
C
|
High
|
158
|
Rotavirus vaccine
|
7,551
|
251
|
C
|
High
|
159
|
Marburg virus disease
|
7,397
|
246
|
C
|
High
|
160
|
COVID-19 pandemic in Russia
|
7,343
|
244
|
C
|
Low
|
161
|
Influenza A virus subtype H5N1
|
7,263
|
242
|
B
|
Top
|
162
|
Rabies in animals
|
7,177
|
239
|
C
|
High
|
163
|
Viral hemorrhagic fever
|
7,171
|
239
|
C
|
High
|
164
|
Swine influenza
|
7,142
|
238
|
B
|
High
|
165
|
Yellow fever vaccine
|
7,082
|
236
|
C
|
High
|
166
|
Subacute sclerosing panencephalitis
|
7,064
|
235
|
C
|
Mid
|
167
|
Wuhan Institute of Virology
|
7,031
|
234
|
C
|
Mid
|
168
|
Virology
|
6,980
|
232
|
B
|
Top
|
169
|
Viral encephalitis
|
6,914
|
230
|
B
|
High
|
170
|
Hershey–Chase experiment
|
6,912
|
230
|
C
|
Mid
|
171
|
Vaccine hesitancy
|
6,871
|
229
|
B
|
High
|
172
|
History of smallpox
|
6,870
|
229
|
C
|
Mid
|
173
|
Cowpox
|
6,786
|
226
|
C
|
Mid
|
174
|
Hantavirus pulmonary syndrome
|
6,774
|
225
|
Start
|
High
|
175
|
DNA polymerase
|
6,750
|
225
|
C
|
Top
|
176
|
Orthopoxvirus
|
6,729
|
224
|
C
|
High
|
177
|
Polio eradication
|
6,587
|
219
|
B
|
Mid
|
178
|
Feline calicivirus
|
6,578
|
219
|
C
|
Top
|
179
|
Watermelon mosaic virus
|
6,479
|
215
|
C
|
Low
|
180
|
Economic impact of the COVID-19 pandemic
|
6,403
|
213
|
B
|
Low
|
181
|
Oncolytic virus
|
6,363
|
212
|
B
|
Mid
|
182
|
Viroid
|
6,309
|
210
|
C
|
High
|
183
|
Host (biology)
|
6,284
|
209
|
GA
|
High
|
184
|
Human T-lymphotropic virus 1
|
6,248
|
208
|
C
|
High
|
185
|
RNA virus
|
6,096
|
203
|
B
|
High
|
186
|
1889–1890 pandemic
|
6,089
|
202
|
C
|
Mid
|
187
|
Henipavirus
|
6,083
|
202
|
C
|
High
|
188
|
Reverse transcriptase
|
6,065
|
202
|
B
|
Top
|
189
|
COVID-19 pandemic in mainland China
|
6,047
|
201
|
C
|
High
|
190
|
Measles vaccine
|
6,039
|
201
|
C
|
Low
|
191
|
RNA polymerase
|
5,985
|
199
|
B
|
High
|
192
|
Hong Kong flu
|
5,977
|
199
|
C
|
Low
|
193
|
Herpes simplex encephalitis
|
5,957
|
198
|
Start
|
Low
|
194
|
SV40
|
5,953
|
198
|
C
|
Mid
|
195
|
Bioterrorism
|
5,952
|
198
|
B
|
Low
|
196
|
Tick-borne encephalitis
|
5,933
|
197
|
Start
|
Low
|
197
|
Xenophobia and racism related to the COVID-19 pandemic
|
5,872
|
195
|
List
|
Low
|
198
|
Subtypes of HIV
|
5,867
|
195
|
C
|
High
|
199
|
Molnupiravir
|
5,863
|
195
|
C
|
Mid
|
200
|
Pithovirus
|
5,830
|
194
|
Redirect
|
NA
|
201
|
Attenuated vaccine
|
5,829
|
194
|
C
|
High
|
202
|
RNA interference
|
5,811
|
193
|
FA
|
High
|
203
|
2022–2023 mpox outbreak in India
|
5,750
|
191
|
C
|
Low
|
204
|
Lyssavirus
|
5,748
|
191
|
C
|
Mid
|
205
|
Chandipura vesiculovirus
|
5,735
|
191
|
Start
|
Low
|
206
|
Poxviridae
|
5,725
|
190
|
C
|
High
|
207
|
Orthomyxoviridae
|
5,696
|
189
|
B
|
High
|
208
|
Oropouche orthobunyavirus
|
5,683
|
189
|
Start
|
Mid
|
209
|
COVID-19 pandemic in Australia
|
5,664
|
188
|
B
|
Low
|
210
|
Human polyomavirus 2
|
5,646
|
188
|
C
|
High
|
211
|
Lady Mary Wortley Montagu
|
5,605
|
186
|
B
|
Low
|
212
|
Lysogenic cycle
|
5,547
|
184
|
C
|
High
|
213
|
Gain-of-function research
|
5,497
|
183
|
Start
|
High
|
214
|
Great Barrington Declaration
|
5,435
|
181
|
B
|
Low
|
215
|
Hepatitis C virus
|
5,416
|
180
|
B
|
Top
|
216
|
COVID-19 vaccination mandates in the United States
|
5,339
|
177
|
Start
|
Low
|
217
|
Parvoviridae
|
5,328
|
177
|
B
|
Mid
|
218
|
COVID-19 testing
|
5,283
|
176
|
B
|
Low
|
219
|
Variolation
|
5,195
|
173
|
C
|
High
|
220
|
Impact of the COVID-19 pandemic on cinema
|
5,136
|
171
|
B
|
Low
|
221
|
Vaccinia
|
5,118
|
170
|
C
|
High
|
222
|
History of virology
|
5,117
|
170
|
B
|
Top
|
223
|
Hammer-headed bat
|
5,070
|
169
|
GA
|
Low
|
224
|
Impact of the COVID-19 pandemic on education
|
5,053
|
168
|
C
|
Low
|
225
|
Lambda phage
|
5,050
|
168
|
B
|
High
|
226
|
Hepatitis B virus
|
5,039
|
167
|
C
|
Top
|
227
|
Transduction (genetics)
|
5,030
|
167
|
C
|
High
|
228
|
Phage therapy
|
5,024
|
167
|
C
|
Top
|
229
|
Severe acute respiratory syndrome coronavirus 2
|
4,984
|
166
|
Redirect
|
NA
|
230
|
Hepatitis E
|
4,981
|
166
|
GA
|
High
|
231
|
Capsid
|
4,969
|
165
|
C
|
Top
|
232
|
COVID-19 pandemic in New Zealand
|
4,897
|
163
|
C
|
Low
|
233
|
Crimean–Congo hemorrhagic fever
|
4,859
|
161
|
C
|
High
|
234
|
Lassa fever
|
4,831
|
161
|
C
|
High
|
235
|
Walter Reed
|
4,823
|
160
|
C
|
Low
|
236
|
Viral envelope
|
4,818
|
160
|
Start
|
Top
|
237
|
Lentivirus
|
4,787
|
159
|
C
|
Mid
|
238
|
COVID-19 pandemic in Canada
|
4,738
|
157
|
B
|
Mid
|
239
|
MERS
|
4,689
|
156
|
B
|
High
|
240
|
Lamivudine
|
4,652
|
155
|
C
|
Mid
|
241
|
List of films impacted by the COVID-19 pandemic
|
4,644
|
154
|
List
|
Mid
|
242
|
MOG antibody disease
|
4,635
|
154
|
C
|
Mid
|
243
|
Virulent Newcastle disease
|
4,623
|
154
|
C
|
High
|
244
|
Flavivirus
|
4,608
|
153
|
B
|
High
|
245
|
Adeno-associated virus
|
4,586
|
152
|
B
|
High
|
246
|
Baltimore classification
|
4,571
|
152
|
B
|
Top
|
247
|
COVID-19 vaccine misinformation and hesitancy
|
4,556
|
151
|
B
|
Top
|
248
|
Feline coronavirus
|
4,554
|
151
|
C
|
Mid
|
249
|
Pandemic H1N1/09 virus
|
4,547
|
151
|
C
|
Mid
|
250
|
DNA virus
|
4,520
|
150
|
C
|
Top
|
251
|
Timeline of the COVID-19 pandemic in 2019
|
4,499
|
149
|
List
|
High
|
252
|
Incertae sedis
|
4,498
|
149
|
C
|
Low
|
253
|
U.S. federal government response to the COVID-19 pandemic
|
4,479
|
149
|
C
|
Mid
|
254
|
Lytic cycle
|
4,404
|
146
|
C
|
High
|
255
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
4,366
|
145
|
C
|
Mid
|
256
|
COVID-19 pandemic in Victoria
|
4,364
|
145
|
C
|
Low
|
257
|
Carcinogenesis
|
4,361
|
145
|
B
|
Mid
|
258
|
Shope papilloma virus
|
4,325
|
144
|
C
|
Mid
|
259
|
Adenovirus infection
|
4,278
|
142
|
Start
|
Mid
|
260
|
Virulence
|
4,256
|
141
|
C
|
High
|
261
|
Malaysian movement control order
|
4,247
|
141
|
B
|
Low
|
262
|
Oncovirus
|
4,230
|
141
|
C
|
Top
|
263
|
Papillomaviridae
|
4,225
|
140
|
B
|
Top
|
264
|
BK virus
|
4,188
|
139
|
B
|
Low
|
265
|
Kaposi's sarcoma-associated herpesvirus
|
4,160
|
138
|
C
|
High
|
266
|
Travel during the COVID-19 pandemic
|
4,098
|
136
|
C
|
Low
|
267
|
Influenza pandemic
|
4,097
|
136
|
B
|
Top
|
268
|
Nipah virus outbreaks in Kerala
|
4,068
|
135
|
C
|
Low
|
269
|
Influenza A virus subtype H3N2
|
4,029
|
134
|
C
|
High
|
270
|
Non-cellular life
|
4,021
|
134
|
Start
|
Low
|
271
|
SARS-CoV-2 Delta variant
|
3,982
|
132
|
C
|
Mid
|
272
|
2001 United Kingdom foot-and-mouth outbreak
|
3,974
|
132
|
C
|
Mid
|
273
|
Richard H. Ebright
|
3,968
|
132
|
Start
|
Mid
|
274
|
Flat wart
|
3,956
|
131
|
Stub
|
Mid
|
275
|
COVID-19 pandemic in Hubei
|
3,955
|
131
|
C
|
Mid
|
276
|
COVID-19 pandemic in the Republic of Ireland
|
3,942
|
131
|
C
|
Low
|
277
|
2022–2023 mpox outbreak in the United States
|
3,925
|
130
|
C
|
Mid
|
278
|
Human alphaherpesvirus 2
|
3,923
|
130
|
Start
|
Mid
|
279
|
COVID-19 pandemic in Italy
|
3,897
|
129
|
C
|
Mid
|
280
|
Enterovirus 68
|
3,832
|
127
|
C
|
Mid
|
281
|
History of COVID-19 vaccine development
|
3,830
|
127
|
C
|
Low
|
282
|
Face masks during the COVID-19 pandemic
|
3,823
|
127
|
C
|
Low
|
283
|
Arbovirus
|
3,810
|
127
|
C
|
Top
|
284
|
Hepatitis D
|
3,779
|
125
|
C
|
Mid
|
285
|
COVID-19 pandemic in Germany
|
3,771
|
125
|
C
|
Low
|
286
|
Carnivore protoparvovirus 1
|
3,769
|
125
|
Start
|
Mid
|
287
|
Powassan virus
|
3,766
|
125
|
C
|
Mid
|
288
|
Ebolavirus
|
3,755
|
125
|
C
|
Mid
|
289
|
MERS-related coronavirus
|
3,732
|
124
|
B
|
High
|
290
|
Picornavirus
|
3,708
|
123
|
B
|
Mid
|
291
|
Eczema herpeticum
|
3,683
|
122
|
Start
|
Low
|
292
|
Escherichia virus T4
|
3,681
|
122
|
Start
|
Mid
|
293
|
Vaccine shedding
|
3,664
|
122
|
Start
|
Mid
|
294
|
African swine fever virus
|
3,651
|
121
|
C
|
High
|
295
|
Zika fever
|
3,641
|
121
|
B
|
High
|
296
|
1977 Russian flu
|
3,641
|
121
|
C
|
Mid
|
297
|
HBsAg
|
3,627
|
120
|
Start
|
High
|
298
|
Usutu virus
|
3,584
|
119
|
Start
|
Low
|
299
|
Rhabdoviridae
|
3,583
|
119
|
C
|
High
|
300
|
COVID-19 vaccination in the United States
|
3,561
|
118
|
Start
|
Low
|
301
|
Sense (molecular biology)
|
3,528
|
117
|
C
|
High
|
302
|
Ebola virus cases in the United States
|
3,526
|
117
|
C
|
High
|
303
|
GS-441524
|
3,511
|
117
|
Start
|
Low
|
304
|
COVID-19 pandemic in Singapore
|
3,496
|
116
|
B
|
High
|
305
|
Metagenomics
|
3,486
|
116
|
GA
|
High
|
306
|
Tecovirimat
|
3,478
|
115
|
C
|
Mid
|
307
|
Human alphaherpesvirus 1
|
3,474
|
115
|
Start
|
Mid
|
308
|
Giant virus
|
3,471
|
115
|
C
|
High
|
309
|
Ivermectin during the COVID-19 pandemic
|
3,456
|
115
|
B
|
Low
|
310
|
COVID-19 pandemic in New York City
|
3,449
|
114
|
Start
|
Low
|
311
|
Strain (biology)
|
3,440
|
114
|
C
|
High
|
312
|
Echovirus
|
3,424
|
114
|
List
|
Mid
|
313
|
Simian immunodeficiency virus
|
3,413
|
113
|
C
|
High
|
314
|
COVID-19 vaccination in India
|
3,407
|
113
|
C
|
Low
|
315
|
COVID-19 pandemic on cruise ships
|
3,402
|
113
|
B
|
High
|
316
|
Positive-strand RNA virus
|
3,397
|
113
|
C
|
High
|
317
|
Timeline of the COVID-19 pandemic in Canada
|
3,383
|
112
|
B
|
Mid
|
318
|
Impact of the COVID-19 pandemic on the video game industry
|
3,334
|
111
|
C
|
Low
|
319
|
Measles virus
|
3,331
|
111
|
C
|
Top
|
320
|
Rabbit hemorrhagic disease
|
3,323
|
110
|
B
|
Mid
|
321
|
Viral replication
|
3,299
|
109
|
C
|
Top
|
322
|
Alphavirus
|
3,299
|
109
|
B
|
Mid
|
323
|
Inclusion bodies
|
3,276
|
109
|
C
|
High
|
324
|
Australian bat lyssavirus
|
3,271
|
109
|
C
|
Low
|
325
|
Rubella virus
|
3,223
|
107
|
C
|
High
|
326
|
Obelisk (biology)
|
3,191
|
106
|
Start
|
High
|
327
|
Spike protein
|
3,170
|
105
|
Start
|
Low
|
328
|
Negative-strand RNA virus
|
3,161
|
105
|
B
|
Mid
|
329
|
Marek's disease
|
3,158
|
105
|
C
|
Mid
|
330
|
COVID-19 pandemic in North Korea
|
3,091
|
103
|
B
|
Mid
|
331
|
1957–1958 influenza pandemic
|
3,066
|
102
|
C
|
Mid
|
332
|
Koplik's spots
|
3,037
|
101
|
C
|
Mid
|
333
|
White House Coronavirus Task Force
|
3,036
|
101
|
C
|
Low
|
334
|
Pod People (Invasion of the Body Snatchers)
|
3,025
|
100
|
Start
|
Low
|
335
|
Timeline of human vaccines
|
3,022
|
100
|
List
|
Low
|
336
|
New York COVID-19 nursing home scandal
|
3,022
|
100
|
B
|
Low
|
337
|
COVID-19 lockdown in China
|
2,977
|
99
|
C
|
High
|
338
|
Intracellular parasite
|
2,976
|
99
|
Start
|
Mid
|
339
|
Endogenous retrovirus
|
2,959
|
98
|
C
|
Mid
|
340
|
COVID-19 pandemic in Japan
|
2,942
|
98
|
C
|
Low
|
341
|
Viral evolution
|
2,934
|
97
|
C
|
High
|
342
|
Coronavirus spike protein
|
2,905
|
96
|
Start
|
Low
|
343
|
Deer cutaneous fibroma
|
2,902
|
96
|
Start
|
Low
|
344
|
Paramyxoviridae
|
2,885
|
96
|
C
|
High
|
345
|
Mpox in the Philippines
|
2,878
|
95
|
C
|
Low
|
346
|
COVID-19 pandemic on Diamond Princess
|
2,859
|
95
|
Start
|
Low
|
347
|
Hendra virus
|
2,834
|
94
|
Start
|
Mid
|
348
|
Human betaherpesvirus 5
|
2,834
|
94
|
C
|
High
|
349
|
Natural reservoir
|
2,828
|
94
|
C
|
High
|
350
|
2019 Samoa measles outbreak
|
2,803
|
93
|
C
|
Low
|
351
|
SARS-related coronavirus
|
2,775
|
92
|
C
|
High
|
352
|
Viral shedding
|
2,770
|
92
|
Start
|
High
|
353
|
Flu season
|
2,759
|
91
|
C
|
High
|
354
|
COVID-19 pandemic in New South Wales
|
2,731
|
91
|
B
|
Low
|
355
|
List of unproven methods against COVID-19
|
2,701
|
90
|
List
|
Mid
|
356
|
HIV vaccine development
|
2,698
|
89
|
C
|
Mid
|
357
|
B virus
|
2,692
|
89
|
C
|
Mid
|
358
|
HIV superinfection
|
2,682
|
89
|
C
|
Mid
|
359
|
Phage display
|
2,673
|
89
|
C
|
Mid
|
360
|
COVID-19 pandemic in Europe
|
2,672
|
89
|
C
|
Low
|
361
|
Feed a cold, starve a fever
|
2,648
|
88
|
C
|
Low
|
362
|
Human virome
|
2,627
|
87
|
C
|
Mid
|
363
|
Rift Valley fever
|
2,618
|
87
|
C
|
High
|
364
|
COVID-19 pandemic in Tamil Nadu
|
2,608
|
86
|
C
|
Low
|
365
|
Filoviridae
|
2,607
|
86
|
Start
|
High
|
366
|
Rolling circle replication
|
2,598
|
86
|
C
|
Mid
|
367
|
Impact of the COVID-19 pandemic on the environment
|
2,598
|
86
|
C
|
Low
|
368
|
Psittacine beak and feather disease
|
2,567
|
85
|
Start
|
Mid
|
369
|
Mimivirus
|
2,563
|
85
|
C
|
Mid
|
370
|
Solid lipid nanoparticle
|
2,534
|
84
|
C
|
Low
|
371
|
Riboviria
|
2,529
|
84
|
B
|
Top
|
372
|
Superinfection
|
2,507
|
83
|
Stub
|
Mid
|
373
|
Impact of the COVID-19 pandemic on sports
|
2,490
|
83
|
C
|
Mid
|
374
|
List of biosafety level 4 organisms
|
2,480
|
82
|
List
|
Low
|
375
|
HIV trial in Libya
|
2,470
|
82
|
B
|
Low
|
376
|
Innate resistance to HIV
|
2,464
|
82
|
C
|
High
|
377
|
Orf (disease)
|
2,442
|
81
|
Start
|
Low
|
378
|
Molluscum contagiosum virus
|
2,439
|
81
|
C
|
Mid
|
379
|
Orthonairovirus
|
2,437
|
81
|
Start
|
Low
|
380
|
Coxsackie A virus
|
2,433
|
81
|
Start
|
Mid
|
381
|
Discrimination against people with HIV/AIDS
|
2,430
|
81
|
C
|
High
|
382
|
History of coronavirus
|
2,427
|
80
|
B
|
Mid
|
383
|
Vertically transmitted infection
|
2,421
|
80
|
C
|
High
|
384
|
Face masks during the COVID-19 pandemic in the United States
|
2,419
|
80
|
C
|
Low
|
385
|
List of Ebola outbreaks
|
2,416
|
80
|
List
|
Low
|
386
|
Coxsackie B virus
|
2,408
|
80
|
C
|
Mid
|
387
|
Congenital rubella syndrome
|
2,405
|
80
|
Start
|
Mid
|
388
|
Saint Louis encephalitis
|
2,388
|
79
|
C
|
Mid
|
389
|
COVID-19 pandemic in Maharashtra
|
2,387
|
79
|
C
|
Low
|
390
|
RNA-dependent RNA polymerase
|
2,385
|
79
|
C
|
Top
|
391
|
Transmission of COVID-19
|
2,383
|
79
|
C
|
High
|
392
|
Ebola vaccine
|
2,377
|
79
|
C
|
Mid
|
393
|
Virgin cleansing myth
|
2,369
|
78
|
Start
|
Low
|
394
|
Human coronavirus OC43
|
2,332
|
77
|
C
|
Mid
|
395
|
Chinese government response to COVID-19
|
2,300
|
76
|
B
|
Mid
|
396
|
U.S. state and local government responses to the COVID-19 pandemic
|
2,288
|
76
|
C
|
Mid
|
397
|
Mumps virus
|
2,282
|
76
|
B
|
High
|
398
|
Ebola virus
|
2,281
|
76
|
Redirect
|
NA
|
399
|
Timeline of the COVID-19 pandemic in January 2020
|
2,275
|
75
|
List
|
High
|
400
|
Jonathan Van-Tam
|
2,261
|
75
|
C
|
Low
|
401
|
Orthornavirae
|
2,252
|
75
|
B
|
High
|
402
|
Human coronavirus NL63
|
2,250
|
75
|
C
|
Low
|
403
|
1793 Philadelphia yellow fever epidemic
|
2,250
|
75
|
C
|
Low
|
404
|
Plant virus
|
2,234
|
74
|
C
|
Top
|
405
|
Kyasanur Forest disease
|
2,231
|
74
|
B
|
Mid
|
406
|
Sedoreoviridae
|
2,209
|
73
|
C
|
Mid
|
407
|
Bat virome
|
2,208
|
73
|
GA
|
High
|
408
|
DNA vaccine
|
2,207
|
73
|
Start
|
Low
|
409
|
Heterophile antibody test
|
2,206
|
73
|
C
|
Low
|
410
|
Virus latency
|
2,181
|
72
|
C
|
High
|
411
|
Antibody-dependent enhancement
|
2,176
|
72
|
C
|
High
|
412
|
Primate T-lymphotropic virus
|
2,174
|
72
|
C
|
High
|
413
|
Deployment of COVID-19 vaccines
|
2,146
|
71
|
C
|
High
|
414
|
Flaviviridae
|
2,139
|
71
|
Start
|
High
|
415
|
COVID-19 pandemic in Pakistan
|
2,136
|
71
|
B
|
Low
|
416
|
Superspreading event
|
2,132
|
71
|
C
|
High
|
417
|
COVID-19 pandemic in South Africa
|
2,131
|
71
|
B
|
Mid
|
418
|
List of virus species
|
2,114
|
70
|
List
|
Top
|
419
|
COVID-19 pandemic in California
|
2,114
|
70
|
C
|
Mid
|
420
|
Fowlpox
|
2,104
|
70
|
Start
|
Low
|
421
|
2020–21 Singapore circuit breaker measures
|
2,104
|
70
|
C
|
Low
|
422
|
Polyomaviridae
|
2,089
|
69
|
C
|
High
|
423
|
Structure and genome of HIV
|
2,086
|
69
|
B
|
High
|
424
|
Enhanced community quarantine in Luzon
|
2,084
|
69
|
B
|
Low
|
425
|
Conjugate vaccine
|
2,078
|
69
|
C
|
High
|
426
|
Viral vector vaccine
|
2,073
|
69
|
Start
|
Low
|
427
|
Caliciviridae
|
2,071
|
69
|
C
|
Mid
|
428
|
Pleomorphism (microbiology)
|
2,065
|
68
|
C
|
High
|
429
|
SARS-CoV-2 Alpha variant
|
2,063
|
68
|
C
|
Low
|
430
|
Timeline of the COVID-19 pandemic in March 2020
|
2,030
|
67
|
List
|
High
|
431
|
Communication of the Trump administration during the COVID-19 pandemic
|
2,019
|
67
|
C
|
Low
|
432
|
Astrovirus
|
2,017
|
67
|
B
|
Low
|
433
|
Spillover infection
|
2,009
|
66
|
Start
|
Mid
|
434
|
Viral load
|
1,991
|
66
|
Start
|
Mid
|
435
|
Feline viral rhinotracheitis
|
1,981
|
66
|
C
|
Top
|
436
|
Timeline of the COVID-19 pandemic in the United Kingdom (2024)
|
1,978
|
65
|
List
|
Low
|
437
|
Emerging infectious disease
|
1,966
|
65
|
Start
|
Low
|
438
|
COVID-19 pandemic in Malaysia
|
1,964
|
65
|
B
|
High
|
439
|
COVID-19 pandemic in Sweden
|
1,958
|
65
|
B
|
Low
|
440
|
HIV/AIDS in Russia
|
1,950
|
65
|
Start
|
Low
|
441
|
Timeline of the COVID-19 pandemic in New York City
|
1,937
|
64
|
Start
|
Low
|
442
|
Reston virus
|
1,935
|
64
|
C
|
Low
|
443
|
COVID-19 pandemic in Hong Kong
|
1,924
|
64
|
C
|
Low
|
444
|
Bunyavirales
|
1,923
|
64
|
C
|
Mid
|
445
|
List of diseases of the honey bee
|
1,915
|
63
|
List
|
High
|
446
|
Impact of the COVID-19 pandemic on commercial air transport
|
1,914
|
63
|
C
|
Low
|
447
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
1,912
|
63
|
List
|
Low
|
448
|
Wetland virus
|
1,910
|
63
|
Stub
|
Low
|
449
|
HA-tag
|
1,892
|
63
|
Start
|
High
|
450
|
COVID-19 pandemic in South Korea
|
1,856
|
61
|
B
|
Low
|
451
|
Venezuelan equine encephalitis virus
|
1,855
|
61
|
Start
|
Mid
|
452
|
Hantavirus hemorrhagic fever with renal syndrome
|
1,850
|
61
|
Start
|
High
|
453
|
COVID-19 pandemic in France
|
1,845
|
61
|
B
|
Mid
|
454
|
Political impact of the COVID-19 pandemic
|
1,843
|
61
|
B
|
Low
|
455
|
Peter Daszak
|
1,837
|
61
|
Start
|
Low
|
456
|
Treatment and management of COVID-19
|
1,832
|
61
|
C
|
Mid
|
457
|
European respirator standards
|
1,825
|
60
|
C
|
Mid
|
458
|
Baculoviridae
|
1,824
|
60
|
C
|
Mid
|
459
|
Modified vaccinia Ankara
|
1,820
|
60
|
Start
|
Mid
|
460
|
Ross River virus
|
1,816
|
60
|
C
|
Mid
|
461
|
Lassa mammarenavirus
|
1,803
|
60
|
Start
|
Mid
|
462
|
West Nile virus in the United States
|
1,778
|
59
|
C
|
Low
|
463
|
COVID-19 vaccination in the United Kingdom
|
1,768
|
58
|
C
|
Low
|
464
|
Swedish government response to the COVID-19 pandemic
|
1,763
|
58
|
C
|
Low
|
465
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
1,758
|
58
|
List
|
Low
|
466
|
PEGylation
|
1,750
|
58
|
C
|
Low
|
467
|
Human betaherpesvirus 7
|
1,750
|
58
|
C
|
Mid
|
468
|
Coronaviridae
|
1,749
|
58
|
Start
|
High
|
469
|
Tomato brown rugose fruit virus
|
1,737
|
57
|
C
|
Low
|
470
|
Cervarix
|
1,734
|
57
|
C
|
Mid
|
471
|
Pandoravirus
|
1,728
|
57
|
Start
|
High
|
472
|
Shortages related to the COVID-19 pandemic
|
1,710
|
57
|
B
|
Low
|
473
|
Lymphocytic choriomeningitis
|
1,696
|
56
|
C
|
Mid
|
474
|
Reverse-transcriptase inhibitor
|
1,683
|
56
|
C
|
High
|
475
|
Neurotropic virus
|
1,683
|
56
|
Start
|
High
|
476
|
Banana bunchy top virus
|
1,679
|
55
|
C
|
Mid
|
477
|
Introduction to viruses
|
1,676
|
55
|
FA
|
Top
|
478
|
Koilocyte
|
1,668
|
55
|
Start
|
Low
|
479
|
Pigeon pox
|
1,647
|
54
|
Stub
|
Low
|
480
|
Impact of the COVID-19 pandemic on social media
|
1,646
|
54
|
Start
|
Low
|
481
|
COVID-19 pandemic in New York (state)
|
1,641
|
54
|
C
|
Low
|
482
|
Black flying fox
|
1,637
|
54
|
C
|
Mid
|
483
|
Double-stranded RNA viruses
|
1,618
|
53
|
Start
|
High
|
484
|
HIV/AIDS in Thailand
|
1,617
|
53
|
Start
|
Low
|
485
|
2020–2024 H5N1 outbreak
|
1,607
|
53
|
C
|
Low
|
486
|
Variably protease-sensitive prionopathy
|
1,605
|
53
|
Start
|
Low
|
487
|
Cytopathic effect
|
1,601
|
53
|
C
|
High
|
488
|
COVID-19 pandemic in North America
|
1,600
|
53
|
C
|
Mid
|
489
|
2015–16 Zika virus epidemic
|
1,596
|
53
|
B
|
Mid
|
490
|
1976 Zaire Ebola virus outbreak
|
1,591
|
53
|
C
|
Low
|
491
|
White House COVID-19 outbreak
|
1,591
|
53
|
C
|
Low
|
492
|
Arenavirus
|
1,588
|
52
|
C
|
High
|
493
|
Enterovirus 71
|
1,583
|
52
|
Start
|
High
|
494
|
HIV/AIDS in the Philippines
|
1,573
|
52
|
Start
|
Low
|
495
|
Negri body
|
1,567
|
52
|
Start
|
Mid
|
496
|
Coronavirus diseases
|
1,562
|
52
|
List
|
Low
|
497
|
Derrick Rossi
|
1,551
|
51
|
Start
|
Low
|
498
|
735–737 Japanese smallpox epidemic
|
1,550
|
51
|
C
|
Low
|
499
|
Virophage
|
1,541
|
51
|
C
|
Mid
|
500
|
Realm (virology)
|
1,525
|
50
|
B
|
Top
|